Technology
Health
Biotechnology

Surface Oncology

$4.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.96%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SURF and other stocks, options, ETFs, and crypto commission-free!

About

Surface Oncology, Inc. Common Stock, also called Surface Oncology, is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. Read More The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.

Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
111.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
145.69K
High Today
$4.13
Low Today
$4.00
Open Price
$4.05
Volume
14.14K
52 Week High
$18.18
52 Week Low
$3.45

Collections

Technology
Health
Biotechnology
Medical
Cancer Prevention
2018 IPO
US
North America

News

NasdaqMay 9

Surface Oncology, Inc. (SURF) Reports Q1 Loss, Tops Revenue Estimates

Surface Oncology, Inc. (SURF) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 65.91%. A quarter ago, it was expected that this company would post a loss of $0.69 per share when it actually produced a loss of $0.17, delivering a surprise of 75.36%. Over the last four quarters, the compa...

21

Earnings

-$0.76
-$0.16
$0.45
$1.05
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.15 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.